National Institutes of Health's book
195 companies · priced by our data| Company | Industry | Valuation | $/share | First invested | Role |
|---|---|---|---|---|---|
| Noom | Other Healthcare Services | $3.7B | — | — | |
| Neurona Therapeutics | Drug Discovery | $1.1B | — | — | |
| Visby Medical | — | $866.0M | — | — | |
| OncoC4 | — | $660.0M | — | — | |
| Strand Therapeutics | Drug Discovery | $571.0M | — | — | |
| Vestaron | — | $551.0M | — | — | |
| Biolinq | — | $407.0M | — | — | |
| Synchron | — | $385.0M | — | — | |
| CytoVale | — | $340.0M | — | — | |
| Eko (Monitoring Equipment) | — | $278.0M | — | — | |
| + 185 more companies · a free account shows the top 25 | |||||
Free account
See the whole book
- ·The book's top 25 — of 195 recorded positions
- ·Watchlist + alerts for National Institutes of Health's activity
Create free account
No card required